Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide

This study has been terminated.
Information provided by INO Therapeutics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Pulmonary Hypertension
			Lung Disease
			Sickle Cell Disease
			Cardiac Transplant
			Lung Transplant
2		Additional conditions recognized in this trial
			Anemia, Sickle Cell
			Hypertension
			Hypertension, Pulmonary
			Lung Diseases
			Pulmonary Heart Disease
3		More general conditions related to this trial
			Anemia
			Anemia, Hemolytic
			Anemia, Hemolytic, Congenital
			Cardiovascular Diseases
			Genetic Diseases, Inborn
			Heart Diseases
			Hematologic Diseases
			Hemoglobinopathies
			Respiratory Tract Diseases
			Vascular Diseases
4		Interventions listed in this trial
			Inhaled Nitric Oxide
5		Additional drug interventions recognized in this trial
			Nitric Oxide
6		More general drug interventions related to this trial
			Anti-Asthmatic Agents
			Antioxidants
			Autonomic Agents
			Bronchodilator Agents
			Cardiovascular Agents
			Endothelium-Dependent Relaxing Factors
			Free Radical Scavengers
			Molecular Mechanisms of Pharmacological Action
			Neurotransmitter Agents
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Protective Agents
			Respiratory System Agents
			Therapeutic Uses
			Vasodilator Agents
7		Sponsors listed in this trial
			INO Therapeutics